Accuitive Medical Ventures
55
21M
20
2.62
5
0.64
12
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Duluth. The venture was found in North America in United States.
The real fund results show that this VC is 8 percentage points less often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Accuitive Medical Ventures is 100-500 millions dollars. The high activity for fund was in 2007. Opposing the other organizations, this Accuitive Medical Ventures works on 10 percentage points less the average amount of lead investments.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight AcuFocus, NeoVista, AxoGen. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Information Technology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Accuitive Medical Ventures, startups are often financed by ONSET Ventures, MPM Capital, DeNovo Ventures. The meaningful sponsors for the fund in investment in the same round are Investor Growth Capital Limited, DeNovo Ventures, MPM Capital. In the next rounds fund is usually obtained by Three Arch Partners, Investor Growth Capital Limited, MPM Capital.
The current fund was established by Charles E. Larsen, Gerard van Hamel Platerink, Thomas D. Weldon. Besides them, we counted 2 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 55
- Lead investments
- 5
- Exits
- 12
- Rounds per year
- 2.62
- Follow on index
- 0.64
- Investments by industry
- Health Care (42)
- Medical Device (38)
- Biotechnology (27)
- Medical (22)
- Pharmaceutical (12) Show 8 more
- Investments by region
-
- United States (55)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 40M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.17
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
AcuFocus | 01 Jan 2005 | Health Care, Medical Device, Medical | Late Stage Venture | 29M | United States, California, Irvine |
CELLutions Biosystems | 16 Dec 2008 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 8M | United States, Georgia |
Qingneng Technology | 11 May 2022 | Information Technology, Information Services, Consulting | Seed | Hunan, Hunan, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.